Irell & Manella
David Gindler focuses on IP disputes, with an emphasis on complex patent litigation. Recognised nationally by Chambers for his expertise in life sciences matters, Gindler’s work spans a broad array of industries and technologies. He has achieved extraordinary trial outcomes for both plaintiffs and defendants, including obtaining a $302 million verdict for breach of a research and licence agreement, as well as defeating a $217 million damages claim where liability had already been established in an earlier trial. He has also delivered remarkable outcomes before the PTAB on behalf of global biotechnology companies.